Market Research Report 2022 of Disposable Upstream Bioprocessing Technologies / Equipment

DUBLIN, June 8, 2022 / PRNewswire / – “Single-Use Upstream Bioprocessing Technology / Equipment by Product Type, Operational Scale, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to by offer.

Logo Research and Markets

The “Single Use Upstream Bioprocessing Equipment / Technologies Market” report presents an in-depth study of the current landscape and likely future potential of developers of single-use upstream bioprocessing technologies and equipment over the next 15 years. The study also presents an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.

One of the key objectives of the report was to understand key growth drivers and estimate the future size of the single-use upstream bioprocessing technologies / equipment market. Based on multiple parameters, such as the overall market for upstream bioprocessing equipment and the share of single-use technology, we have provided an informed estimate of market evolution for the period 2022-2035.

Over time, organic products have gained considerable popularity due to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications that would otherwise be difficult to treat. The success of these interventions prompted interested parties to update the traditional production technology of organic products. The demand for higher productivity and flexibility, higher profitability and faster time to market are further driving the replacement of traditional stainless steel equipment with single-use technologies.

These technologies have been well accepted in a relatively shorter period of time and have become an important tool in the development of various biotechnological processes. Additionally, the ongoing COVID-19 pandemic has prompted the biopharmaceutical industry to switch to single-use technology. These technologies not only reduce footprint requirements, but also eliminate cleaning costs in the development phase.

Furthermore, single-use technologies have the potential to address a number of challenges associated with traditional bio-treatment systems and offer various additional benefits, such as reduced water and energy consumption (by approximately 45%), lower initial investment cost ( by 40%), shorter time to process organic products (by 33%), decreased risk of cross contamination (by 8%) and increased cost savings potential (by 30-40%).

In addition to other elements, the study includes:

  • A detailed assessment of the general market landscape for single-use bioreactors based on a number of relevant parameters, such as operational scale (laboratory, clinical and commercial), type of cell culture system (2D culture and 3D culture), type of cell culture (mammal, insect, microbial, viral, plant and others), molecule type (vaccine, monoclonal antibody, recombinant protein, stem cells, cell therapy, gene therapy and others), key features (touch screen, remote monitoring, build – in the system control sensors, electronic log, alarm system), application area (stem cell research, cancer research, regenerative medicine, drug discovery and others) and end users (pharmaceutical / biopharmaceutical, manufacturing organization a contract, contract research organization and academic institutions). It also features details of companies developing single-use bioreactors, highlighting their founding year, company size and geographic presence.

  • A detailed assessment of the overall market landscape for single-use mixers based on a number of relevant parameters, such as the operational scale (laboratory, clinical and commercial), the type of mixing system (liquid / liquid, solid / liquid and powder / liquid), molecule type (vaccines, biologicals, biosimilars and monoclonal antibodies), key characteristics (visual display / touch screen, ease of use / scalability, integrated system control sensors and process automation) and application area ( media preparation, formulation, swab preparation, viral inactivation and more). It also features details of companies developing single-use bioreactors, highlighting their founding year, company size and geographic presence.

  • A detailed assessment of the overall single-use sensor market landscape, based on several relevant parameters, such as sensor type (conductivity, flow, pH, pressure and temperature), bio-treatment type, measuring range, operating temperature , the sterilization technique, material used) and area of ​​application. In addition, the chapter presents details of companies involved in single-use sensor development, including information on the year of incorporation, company size, and geographic presence.

  • An overview of the general market landscape of other single-use technologies, such as filters, sampling systems and connectors.

  • A detailed analysis of the competitiveness of single-use bioreactors, single-use mixers and single-use sensors, taking into account several relevant parameters. For single-use bioreactors, the parameters considered include the applicability of the product (type of cell culture, type of molecule and area of ​​application) and the strength of the product (type of cell culture system, scale of operation and main characteristics) . For single-use mixers, the parameters considered include the applicability of the product (type of mixing system, type of molecule and area of ​​application) and the strength of the product (scale of operation). For disposable sensors, the parameters taken into consideration include the specificity of the product (minimum operating temperature, maximum operating temperature, type of calibration and type of sterilization technique) and the strength of the product (area of ​​application and type of bio-treatment) .

  • Tabulated profiles of key players providing single-use upstream bioprocessing technologies, which are based in North America, Europe And Asia-Pacific. Each profile includes a company overview, financial performance information (if available), service portfolio, product portfolio, recent developments and informed future prospects.

  • An in-depth analysis of the various patents that have been filed / granted for the single-use upstream bioprocessing technology, up to December 2021, highlighting the key trends associated with these patents, by type of patents, year of publication, year of application, issuing authority involved, type of organizations, emerging area of ​​interest, age of the patent, CPC symbols, main patent holders (in terms of number of patents granted / filed), characteristics of the patent and geography. It also includes detailed patent benchmarking and in-depth valuation analysis.

  • A detailed analysis of the brand positioning of key industry players (including single-use bioreactor developers, single-use mixer developers, and single-use sensor developers), highlighting current perceptions about their proprietary products by taking into consideration several relevant aspects, such as experience of the manufacturer, number of products offered, diversity of products and number of patents published.

  • An in-depth analysis of the time and cost savings potential of single-use upstream bioprocessing technology.

  • An informed estimate on the current and future scenario of supply and demand for single-use upstream bioprocessing technologies, for the period 2022-2035.

For more information on this report, please visit

Media contact:
Research and Markets
Laura WoodChief director
[email protected]

For EST office hours Call + 1-917-300-0470
For US / CAN call toll free + 1-800-526-8630
For GMT office hours Call + 353-1-416-8900

USA Fax: 646-607-1907
Fax (outside the US): + 353-1-481-1716



View original content:

SOURCE Research and Markets

Leave a Comment

Your email address will not be published. Required fields are marked *